The historical rank and industry rank for CNBX Pharmaceuticals's Pretax Margin % or its related term are showing as below:
CNBX'
s Pretax Margin % Range Over the Past 10 Years
Min: -106671.43 Med: -7772.44 Max: 11330
Current: -1343.9
CNBX's Pretax Margin % is ranked worse than 78.25% of 1007
companies
in the Biotechnology industry
Industry Median: -145.13
vs CNBX: -1343.90
CNBX Pharmaceuticals Pretax Margin % Historical Data
The historical data trend for CNBX Pharmaceuticals's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CNBX Pharmaceuticals's Pretax Margin %
For the Biotechnology subindustry, CNBX Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CNBX Pharmaceuticals's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CNBX Pharmaceuticals's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where CNBX Pharmaceuticals's Pretax Margin % falls into.
CNBX Pharmaceuticals Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
CNBX Pharmaceuticals's Pretax Margin for the fiscal year that ended in Aug. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
CNBX Pharmaceuticals Pretax Margin % Related Terms
Thank you for viewing the detailed overview of CNBX Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
CNBX Pharmaceuticals Inc is a clinical-stage biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing HTS technology and personalized bioinformatics tools. The company's main focus is the development of cannabinoid therapies and other technologies for the treatment of cancer, mainly cancers of the gastrointestinal tract, skin, breast, and prostate. The firm's main product is the Cannabics SR, an oral capsule developed for the treatment of patients with cancer and cancer anorexia cachexia syndrome (CACS). It also has an anti-neoplastic drug candidate under development for Colorectal Cancer (CRC) named RCC-33.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CNBX has been successfully added to your 